Swiss Life Asset Management’s Astrana Health ASTH Stock Holding History

Swiss Life Asset Management’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$338K	Buy	+7,287	New	+$262K	﹤0.01%	1183

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Swiss Life Asset Management's ASTH Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in Astrana Health (ASTH) in Q2 2026: 7,287 shares worth $338K. The stake represents ﹤0.01% of the portfolio and ranks #1183 among its holdings.

132 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Swiss Life Asset Management held 7,287 shares of Astrana Health worth $338K as of Q2 2026.
Astrana Health was a new Swiss Life Asset Management position in Q2 2026.
Astrana Health made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1183 holding.
132 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.